Malina et al., 2001 - Google Patents
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium (III) in cell-free mediaMalina et al., 2001
- Document ID
- 4501963120304573566
- Author
- Malina J
- Novakova O
- Keppler B
- Alessio E
- Brabec V
- Publication year
- Publication venue
- JBIC Journal of Biological Inorganic Chemistry
External Links
Snippet
Modifications of natural DNA by three anticancer heterocyclic ruthenium (III) compounds were studied by methods of molecular biophysics. These methods included DNA binding studies using atomic absorption spectrophotometry, inhibition of restriction endonucleases …
- 229920003013 deoxyribonucleic acid 0 title abstract description 151
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0086—Platinum compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Malina et al. | Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium (III) in cell-free media | |
| Žaludová et al. | DNA interactions of bifunctional dinuclear platinum (II) antitumor agents | |
| Gelasco et al. | Anticancer activity of cisplatin and related complexes | |
| Donahue et al. | Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d (GpG) and d (ApG) DNA adducts of the anticancer drug cisplatin | |
| Farrell et al. | A comparison of chemical reactivity, cytotoxicity, interstrand crosslinking and DNA sequence specificity of bis (platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogs | |
| Brabec | DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair | |
| Sherman et al. | Structural aspects of platinum anticancer drug interactions with DNA | |
| Kašpárková et al. | Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking | |
| Nováková et al. | DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media | |
| Zou et al. | Ligand effects in platinum binding to DNA. A comparison of DNA binding properties for cis-and trans-[PtCl2 (amine) 2](amine= NH3, pyridine) | |
| Loskotová et al. | DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin | |
| Žaludová et al. | The effect of ionic strength on melting of DNA modified by platinum (II) complexes | |
| Mlcouskova et al. | DNA conformation and repair of polymeric natural DNA damaged by antitumor azolato-bridged dinuclear PtII complex | |
| Uerpmann et al. | Design and DNA binding of an extended triple‐stranded metallo‐supramolecular cylinder | |
| Grguric-Sipka et al. | Synthesis, characterization, interaction with DNA and cytotoxicity of the new potential antitumour drug cis-K [Ru (eddp) Cl2] | |
| Pérez et al. | X-ray Structure of Cytotoxic trans-[PtCl2 (dimethylamine)(isopropylamine)]: Interstrand Cross-Link Efficiency, DNA Sequence Specificity, and Inhibition of the B− Z Transition | |
| Olivova et al. | Unique DNA binding mode of antitumor trinuclear tridentate platinum (II) compound | |
| Ushay et al. | Binding of [(dien) PtCl] Cl to poly (dG-dC). poly (dG-dC) facilitates the B→ Z conformational transition | |
| BUTOUR et al. | Effect of the amine non‐leaving group on the structure and stability of DNA complexes with cis‐[Pt (R‐NH2) 2 (NO3) 2] | |
| Muchova et al. | Antitumor bifunctional dinuclear PtII complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions | |
| Saad et al. | NMR studies of models having the Pt (d (GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands | |
| Wu et al. | Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex | |
| Murchie et al. | T4 endonuclease VII cleaves DNA containing a cisplatin adduct | |
| Darsillo et al. | The use of chemical nucleases to analyze RNA-protein interactions. The TFIIIA-5 S rRNA complex. | |
| Neplechová et al. | DNA interactions of new antitumor aminophosphine platinum (II) complexes |